ArticleScientific reports2025
Large-scale proteomic analysis of aqueous humor from patients with primary open angle and exfoliation glaucoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A large-scale proteomic approach was used to evaluate the protein profiles of aqueous humor obtained from patients with primary open angle glaucoma (POAG) and exfoliation glaucoma (EXG). The study population consisted of 15 POAG and 15 EXG patients, and 10 patients with no previous ophthalmic treatment as controls. Aqueous humor was collected at the beginning of surgery. Proteins were analyzed using the SOMAscan platform. Among the 7,335 human proteins identified in the aqueous humor of POAG and EXG patients, 215 and 330, respectively, were upregulated, as compared to controls. A pathway-enrichment analysis of the proteins upregulated in both POAG and EXG revealed enrichment of those involved in trabecular meshwork remodeling. Among the 43 and 23 proteins downregulated in POAG and EXG, respectively, was GSTP1, whose null genotype has been shown to increase the risk of POAG in Asians. SOMAscan analysis of the aqueous humor proteins of POAG and EXG patients revealed enrichment of pathways related to the onset and progression of glaucoma, as well as novel disease-associated proteins. These results demonstrate the advantages of SOMAscan, including its high detection sensitivity and accuracy even in analyses of a small number of samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.